Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDER “Sentencing Guidelines” To Provide Enforcement Clarity

Executive Summary

Janet Woodcock says effort will help standardize its compliance process and ensure penalties fit violations, but one attorney says they may be difficult to implement.


Related Content

How FDA Plans To Stop Worrying And Love Globalization
FDA Could Release GMP Data To Prod Manufacturing Improvements
Pharmaceutical Quality And Generic Drugs: Janet Woodcock Explains Her Vision
Regulatory Flexibility Staring Contest: Will Industry Or FDA Blink First?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts